These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 1663787)
21. Utilizing protein phosphatase inhibitors to define PP2A as a regulator of ataxia-telangiectasia mutated. Goodarzi AA; Douglas P; Moorhead GB; Lees-Miller SP Methods Mol Biol; 2007; 365():47-59. PubMed ID: 17200553 [TBL] [Abstract][Full Text] [Related]
22. Transforming collaborations between ras and nuclear oncogenes. Ruley HE Cancer Cells; 1990; 2(8-9):258-68. PubMed ID: 2223387 [TBL] [Abstract][Full Text] [Related]
23. Signaling and transcriptional changes critical for transformation of human cells by simian virus 40 small tumor antigen or protein phosphatase 2A B56gamma knockdown. Moreno CS; Ramachandran S; Ashby DG; Laycock N; Plattner CA; Chen W; Hahn WC; Pallas DC Cancer Res; 2004 Oct; 64(19):6978-88. PubMed ID: 15466190 [TBL] [Abstract][Full Text] [Related]
24. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf. Topol LZ; Marx M; Calothy G; Blair DG Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484 [TBL] [Abstract][Full Text] [Related]
25. Cyclic 3,5 adenoise monophosphate and cyclosporin A inhibit cellular proliferation and serine/threonine protein phosphatase activity in pituitary cells. Florio T; Perrino BA; Stork PJ Endocrinology; 1996 Oct; 137(10):4409-18. PubMed ID: 8828502 [TBL] [Abstract][Full Text] [Related]
26. Protein phosphorylation and signal transduction modulation: chemistry perspectives for small-molecule drug discovery. Sawyer TK; Shakespeare WC; Wang Y; Sundaramoorthi R; Huang WS; Metcalf CA; Thomas M; Lawrence BM; Rozamus L; Noehre J; Zhu X; Narula S; Bohacek RS; Weigele M; Dalgarno DC Med Chem; 2005 May; 1(3):293-319. PubMed ID: 16787325 [TBL] [Abstract][Full Text] [Related]
27. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Yeh E; Cunningham M; Arnold H; Chasse D; Monteith T; Ivaldi G; Hahn WC; Stukenberg PT; Shenolikar S; Uchida T; Counter CM; Nevins JR; Means AR; Sears R Nat Cell Biol; 2004 Apr; 6(4):308-18. PubMed ID: 15048125 [TBL] [Abstract][Full Text] [Related]
28. Roles of protein kinases and phosphatases in signal transduction. Hardie DG Symp Soc Exp Biol; 1990; 44():241-55. PubMed ID: 1966636 [TBL] [Abstract][Full Text] [Related]
29. Small DNA tumor viruses: large contributors to biomedical sciences. Howley PM; Livingston DM Virology; 2009 Feb; 384(2):256-9. PubMed ID: 19136134 [TBL] [Abstract][Full Text] [Related]
30. The serine/threonine phosphatase inhibitor, calyculin A, inhibits and dissociates macrophage responses to lipopolysaccharide. Barber SA; Perera PY; McNally R; Vogel SN J Immunol; 1995 Aug; 155(3):1404-10. PubMed ID: 7636205 [TBL] [Abstract][Full Text] [Related]
31. Regulation of gene expression by serine/threonine protein phosphatases. Schönthal AH Semin Cancer Biol; 1995 Aug; 6(4):239-48. PubMed ID: 8541519 [TBL] [Abstract][Full Text] [Related]
32. [Role of protein phosphorylation in the development of tumors]. Majercáková P Sb Lek; 2000; 101(3):215-28. PubMed ID: 11220149 [TBL] [Abstract][Full Text] [Related]
33. Protein serine/threonine phosphatases--new avenues for cell regulation. Shenolikar S Annu Rev Cell Biol; 1994; 10():55-86. PubMed ID: 7888183 [No Abstract] [Full Text] [Related]
34. How DNA viruses may cause cancer. Marx JL Science; 1989 Feb; 243(4894 Pt 1):1012-3. PubMed ID: 2538000 [No Abstract] [Full Text] [Related]
35. Involvement of PP2A in viral and cellular transformation. Arroyo JD; Hahn WC Oncogene; 2005 Nov; 24(52):7746-55. PubMed ID: 16299534 [TBL] [Abstract][Full Text] [Related]
36. Targeting of PKA, PKC and protein phosphatases to cellular microdomains. Sim AT; Scott JD Cell Calcium; 1999 Nov; 26(5):209-17. PubMed ID: 10643559 [TBL] [Abstract][Full Text] [Related]
37. [Carcinogenesis: viruses and transposons]. Zhdanov VM Vopr Onkol; 1984; 30(1):98-104. PubMed ID: 6320545 [No Abstract] [Full Text] [Related]
38. Flicking the switches: phosphorylation of serine/threonine protein phosphatases. Brautigan DL Semin Cancer Biol; 1995 Aug; 6(4):211-7. PubMed ID: 8541516 [TBL] [Abstract][Full Text] [Related]
39. Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. Zuo Z; Urban G; Scammell JG; Dean NM; McLean TK; Aragon I; Honkanen RE Biochemistry; 1999 Jul; 38(28):8849-57. PubMed ID: 10413457 [TBL] [Abstract][Full Text] [Related]
40. Wip1-dependent signaling pathways in health and diseases. Zhu YH; Bulavin DV Prog Mol Biol Transl Sci; 2012; 106():307-25. PubMed ID: 22340722 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]